null

SMILES: OCc1ccccc1-c1ccc(cc1)N1CCC[C@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O

InChI Key: InChIKey=JEDFNJOSLDVDIO-QHCPKHFHSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454186   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454186 (US10717708, Example 58 | US11186544, Example 58) Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C26H24F3N3O3/c27-26(28,29)19-9-11-20(12-10-19)30-25(35)31-23-6-3-15-32(24(23)34)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-33/h1-2,4-5,7-14,23,33H,3,6,15-16H2,(H2,30,31,35)/t23-/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	9.20	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454186 (US10717708, Example 58 | US11186544, Example 58) Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C26H24F3N3O3/c27-26(28,29)19-9-11-20(12-10-19)30-25(35)31-23-6-3-15-32(24(23)34)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-33/h1-2,4-5,7-14,23,33H,3,6,15-16H2,(H2,30,31,35)/t23-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	280	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454186 (US10717708, Example 58 | US11186544, Example 58) Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C26H24F3N3O3/c27-26(28,29)19-9-11-20(12-10-19)30-25(35)31-23-6-3-15-32(24(23)34)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-33/h1-2,4-5,7-14,23,33H,3,6,15-16H2,(H2,30,31,35)/t23-/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	9.20	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454186 (US10717708, Example 58 | US11186544, Example 58) Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C26H24F3N3O3/c27-26(28,29)19-9-11-20(12-10-19)30-25(35)31-23-6-3-15-32(24(23)34)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-33/h1-2,4-5,7-14,23,33H,3,6,15-16H2,(H2,30,31,35)/t23-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	280	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair